Editorial
Editorial preface to this special issue “Improving the quality and outcomes of lung cancer care: an interdisciplinary approach”
Review Article
Global trends of lung cancer mortality and smoking prevalence
Integration of tobacco cessation services into multidisciplinary lung cancer care: rationale, state of the art, and future directions
Implementing lung cancer screening in the real world: opportunity, challenges and solutions
What is quality, and can we define it in lung cancer?—the case for quality improvement
Measuring improvement in populations: implementing and evaluating successful change in lung cancer care
Lung cancer care: the impact of facilities and area measures
Lung cancer diagnosis and staging in the minimally invasive age with increasing demands for tissue analysis
Computer modeling of lung cancer diagnosis-to-treatment process
Perspective
Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age—challenges and opportunities
Improving lung cancer outcomes by improving the quality of surgical care
Improving the pathologic evaluation of lung cancer resection specimens
Triaging early-stage lung cancer patients into non-surgical pathways: who, when, and what?
Implementing effective and sustainable multidisciplinary clinical thoracic oncology programs
Original Article
‘One-stop shop’: lung cancer patients’ and caregivers’ perceptions of multidisciplinary care in a community healthcare setting
Erlotinib therapy after initial platinum doublet therapy in patients with EGFR wild type non-small cell lung cancer: results of a combined patient-level analysis of the NCIC CTG BR.21 and SATURN trials
Controversies on Lung Cancer: Pros and Cons (Section Chairs: Suresh Senan, Helmut H. Popper)2
Exploring controversies in lung cancer using structured pro-con debates
Pros: long-term CT scan follow-up should be the standard of care in patients who are curatively treated for an early-stage non-small cell lung cancer
Cons: long-term CT-scan follow-up is not the standard of care in patients curatively treated for an early stage non-small cell lung cancer
Rebuttal from Dr Hanna
Rebuttal from Dr van Meerbeeck
Evidence-Based Medicine3
A meta-analysis of safety and efficacy on first-line S-1 therapy in cancer patients
Meet the Professor4
Professor Caicun Zhou: a successful step forward for international exchange on combating lung cancer
Disclosure:
1. The focused issue “Improving the Quality and Outcomes of Lung Cancer Care: An Interdisciplinary Approach” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Raymond U. Osarogiagbon served as the unpaid Guest Editor for the focused issue.
2. The series “Controversies on Lung Cancer: Pros and Cons” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Suresh Senan and Helmut H. Popper served as the unpaid Guest Editors for the series.
3. The series “Evidence-Based Medicine” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
4. The series “Meet the Professor” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.
